إعلان مُمول
Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say
نشر بتاريخ
India’s pharma sector has downplayed the impact of US President Trump’s 25% tariff, warning instead of severe consequences for American healthcare. Industry leaders stressed India’s key role in supplying affordable medicines to the US and predicted shortages, higher costs, and a 3–5 year struggle for the US to find alternatives.
البحث
الأقسام
- National
- International
- Business
- Technology
- Health
- التعليم
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
إقرأ المزيد
Official! Pakistan impose blanket ban on future WCL participation - details inside
The Pakistan Cricket Board (PCB) has officially banned participation in future World Championship...
IND vs ENG: Washington and Prasidh creates a unique history - Details inside
Washington Sundar and Prasidh Krishna's unbeaten 39-run partnership set a record for India, with...
Trump’s 25% tariff, penalties raise alarm: Indian exporters fear order cancellations; urgent support sought from government
Indian businesses are worried about potential order cancellations from American clients due to...
Matt Milnes to return to Kent on three-year contract
NEW DELHI: Kent Cricket has announced the signing of pacer Matt Milnes from Yorkshire on a...